Previous studies have shown that the γ-secretase complex, comprised of PS-1, APH-1, PEN-2 and NCSTN, is recognized as a therapeutic option for treating HCC [10, 20–22]. The gene discussed is APH1A; the disease is hepatocellular carcinoma.